Responses
Clinical/translational cancer immunotherapy
Original research
No detrimental association between antibiotic use and immune checkpoint inhibitor therapy: an observational cohort study comparing patients with ICI-treated and TKI-treated melanoma and NSCLC
Compose a Response to This Article
Other responses
No responses have been published for this article.
